BIIB (STOCKS)
Biogen Inc. Common Stock
$210.650000
+1.780000 (+0.85%)
Prev close: $208.870000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Christopher A. Viehbacher
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $32,208.56M
- Employees
- 7,605
- P/E (TTM)
- 36.99
- P/B (TTM)
- 1.64
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
9
Strong Buy
20
Buy
13
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$3.60 | $3.01 | +0.5938 | +19.75% |
|
Mar 2026 (Q1)
|
$3.57 | $2.83 | +0.7442 | +26.34% |
|
Dec 2025 (Q4)
|
$1.99 | $1.65 | +0.3436 | +20.87% |
|
Sep 2025 (Q3)
|
$4.81 | $3.96 | +0.8505 | +21.48% |
Financial Statements
| Revenues | $10.03B |
| Benefits Costs and Expenses | $9.02B |
| Cost Of Revenue | $2.61B |
| Costs And Expenses | $9.02B |
| Gross Profit | $7.42B |
| Operating Expenses | $6.41B |
| Selling, General, and Administrative Expenses | $2.59B |
| Other Operating Expenses | $3.81B |
| Operating Income/Loss | $1.01B |
| Income/Loss From Continuing Operations After Tax | $834.60M |
| Income/Loss From Continuing Operations Before Tax | $1.01B |
| Income Tax Expense/Benefit | $176.80M |
| Income Tax Expense/Benefit, Deferred | $416.70M |
| Interest Expense, Operating | $284.80M |
| Net Income/Loss | $834.60M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $834.60M |
| Net Income/Loss Available To Common Stockholders, Basic | $834.60M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $5.68 |
| Diluted Earnings Per Share | $5.63 |
| Basic Average Shares | 294,100,000 |
| Diluted Average Shares | 296,000,000 |
| Assets | $32.09B |
| Current Assets | $7.31B |
| Inventory | $2.38B |
| Other Current Assets | $4.92B |
| Noncurrent Assets | $24.78B |
| Fixed Assets | $2.99B |
| Intangible Assets | $13.52B |
| Other Non-current Assets | $8.27B |
| Liabilities | $13.24B |
| Current Liabilities | $3.92B |
| Accounts Payable | $403.90M |
| Other Current Liabilities | $3.51B |
| Noncurrent Liabilities | $9.32B |
| Long-term Debt | $7.29B |
| Other Non-current Liabilities | $2.03B |
| Equity | $18.85B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $18.85B |
| Liabilities And Equity | $32.09B |
| Net Cash Flow From Operating Activities | $2.88B |
| Net Cash Flow From Operating Activities, Continuing | $2.88B |
| Net Cash Flow From Investing Activities | -$5.32B |
| Net Cash Flow From Investing Activities, Continuing | -$5.32B |
| Net Cash Flow From Financing Activities | $985.00M |
| Net Cash Flow From Financing Activities, Continuing | $985.00M |
| Exchange Gains/Losses | -$22.10M |
| Net Cash Flow | -$1.47B |
| Net Cash Flow, Continuing | -$1.45B |
| Comprehensive Income/Loss | $945.00M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $945.00M |
| Other Comprehensive Income/Loss | $110.40M |
| Other Comprehensive Income/Loss Attributable To Parent | $31.80M |